Marco Tampellini
About
Marco Tampellini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology.
According to data from OpenAlex, Marco Tampellini has authored 91 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 13 papers in Epidemiology. Recurrent topics in Marco Tampellini's work include Colorectal Cancer Treatments and Studies (32 papers), Cancer Treatment and Pharmacology (23 papers) and Bone health and treatments (14 papers). Marco Tampellini is often cited by papers focused on Colorectal Cancer Treatments and Studies (32 papers), Cancer Treatment and Pharmacology (23 papers) and Bone health and treatments (14 papers). Marco Tampellini collaborates with scholars based in Italy, United States and Canada. Marco Tampellini's co-authors include Luigi Dogliotti, G. Gorzegno, Françis Lévi, Carlo Garufi, Sylvie Giacchetti, C. Focan, Alfredo Berruti, Georg A. Bjarnason, M. Torta and Stefano Iacobelli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
In The Last Decade
Marco Tampellini
89 papers receiving 2.2k citations
Peers
Marco Tampellini
C. Focan Belgium
Hiroaki Kuroda Japan
Carlo Garufi Italy
Marina Elena Cazzaniga Italy
Manuel Benavides Spain
P. Escudero Spain
Rohit Moudgil United States
Benoît Baron France
Joo Ern Ang United Kingdom
Knut Lote Norway
Citations per year, relative to Marco Tampellini Marco Tampellini (= 1×)
peers
C. Focan
Countries citing papers authored by Marco Tampellini
Since
Specialization
Citations
This map shows the geographic impact of Marco Tampellini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Tampellini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Tampellini more than expected).
Fields of papers citing papers by Marco Tampellini
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Marco Tampellini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Tampellini. The network helps show where Marco Tampellini may publish in the future.
Co-authorship network of co-authors of Marco Tampellini
This figure shows the co-authorship network connecting the top 25 collaborators of Marco Tampellini. A scholar is included among the top collaborators of Marco Tampellini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Tampellini. Marco Tampellini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bertaglia, Valentina, Anna Morelli, Cinzia Solinas, et al.. (2023). Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario. Critical Reviews in Oncology/Hematology. 184. 103954–103954.
2.
Raimondi, Alessandra, Giovanni Fucà, Alberto Giovanni Leone, et al.. (2021). Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. ESMO Open. 6(5). 100246–100246.
3.
Morano, Federica, Salvatore Corallo, Maria Di Bartolomeo, et al.. (2018). Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy with either 5FU/LV plus pan or single-agent pan: Translational analyses of the VALENTINO study. Annals of Oncology. 29. viii716–viii716.
4.
Tampellini, Marco, Massimo Di Maïo, Chiara Baratelli, et al.. (2017). Treatment of Patients With Metastatic Colorectal Cancer in a Real-World Scenario: Probability of Receiving Second and Further Lines of Therapy and Description of Clinical Benefit. Clinical Colorectal Cancer. 16(4). 372–376.
5.
Brizzi, Maria Pia, Daniele Pignataro, Marco Tampellini, Giorgio V. Scagliotti, & Massimo Di Maïo. (2016). Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs?. Expert Review of Anticancer Therapy. 16(10). 1053–1062.
6.
Tampellini, Marco, Simone Benedetto, Chiara Baratelli, et al.. (2016). Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions. Anticancer Research. 36(10). 5163–5170.
7.
Tampellini, Marco, Chiara Baratelli, Raffaella Bitossi, et al.. (2015). Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy. Chronobiology International. 32(10). 1359–1366.
8.
Brizzi, Maria Pia, Cristina Sonetto, Marco Tampellini, et al.. (2015). Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature. BMC Cancer. 15(1). 914–914.
9.
Tampellini, Marco, et al.. (2014). The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy. Tumor Biology. 36(3). 1519–1527.
10.
Innominato, Pasquale F., Sylvie Giacchetti, Georg A. Bjarnason, et al.. (2012). Prediction of overall survival through circadian rest‐activity monitoring during chemotherapy for metastatic colorectal cancer. International Journal of Cancer. 131(11). 2684–2692.
11.
Volante, Marco, Valerio Marci, Snezana Andrejevic‐Blant, et al.. (2010). Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 457(5). 521–527.
12.
Borasio, P., Mara Gisabella, Andrea Billè, et al.. (2010). Role of surgical resection in colorectal lung metastases: analysis of 137 patients. International Journal of Colorectal Disease. 26(2). 183–190.
13.
Innominato, Pasquale F., C. Focan, Thierry Gorlia, et al.. (2009). Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer. Cancer Research. 69(11). 4700–4707.
14.
Tampellini, Marco, Marina Longo, Susanna Cappia, et al.. (2007). Co-expression of EGF receptor, TGFα and S6 kinase is significantly associated with colorectal carcinomas with distant metastases at diagnosis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 450(3). 321–328.
15.
Tampellini, Marco, et al.. (2006). Stage IB Malignant Thymoma in a Lynch Syndrome Patient with Multiple Cancers: Response to Incidental Administration of Oxaliplatin and 5-Fluorouracil. Journal of Chemotherapy. 18(4). 433–436.
16.
Berruti, Alfredo, Luigi Dogliotti, Marco Tucci, et al.. (2002). Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases. The International Journal of Biological Markers. 17(4). 244–252.
17.
Berruti, Alfredo, M. Torta, A Termine, et al.. (2001). Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience. Annals of Oncology. 12. S73–S77.
18.
Tampellini, Marco, Alfredo Berruti, G. Gorzegno, et al.. (2001). Independent Factors Predict Supranormal CA 15-3 Serum Levels in Advanced Breast Cancer Patients at First Disease Relapse. Tumor Biology. 22(6). 367–373.
19.
Berruti, Alfredo, Luigi Dogliotti, G. Gorzegno, et al.. (1999). Differential Patterns of Bone Turnover in Relation to Bone Pain and Disease Extent in Bone in Cancer Patients with Skeletal Metastases. Clinical Chemistry. 45(8). 1240–1247.
20.
Berruti, Alfredo, et al.. (1994). Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. European Journal of Cancer. 30(14). 2082–2084.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by C. Focan Breakdown of academic impact, for papers by Hiroaki Kuroda Breakdown of academic impact, for papers by Carlo Garufi Breakdown of academic impact, for papers by Marina Elena Cazzaniga Breakdown of academic impact, for papers by Manuel Benavides Breakdown of academic impact, for papers by P. Escudero Breakdown of academic impact, for papers by Rohit Moudgil Breakdown of academic impact, for papers by Benoît Baron Breakdown of academic impact, for papers by Joo Ern Ang Breakdown of academic impact, for papers by Knut Lote